NAALADL2 and prostate carcinoma: Genome-wide association studies (GWAS) have linked single-nucleotide polymorphisms (SNPs) in NAALADL2 to risk in breast and lung cancers and several studies have identified SNPs within the NAALADL2 locus that are associated with prostate cancer risk or aggression20,22–25.